Venous thromboembolism (VTE) is a major preventable disease that affects hospitalized
inpatients. Risk stratification and prophylactic measures have good evidence supporting …

Background Venous thromboembolism (VTE) is a major preventable cause of morbidity,
disability, and mortality in subjects with cancer. A global appraisal of cancer-associated VTE …

Disease burden of venous thromboembolism (VTE) without pharmacologic prophylaxis is
high in trauma patients. Although VTE prophylaxis guidelines exist, studies on real-world …

It takes an average of 17 years for research knowledge to translate into clinical practice.
Implementation research aims to reduce the “know-do” gap between evidence and practice …

Purpose To determine barriers to preventing venous thromboembolism in total knee and hip
arthroplasty patients by surgical nurses. Methods This qualitative study used a …

Background Many hospitalized patients are not administered prescribed doses of
pharmacologic venous thromboembolism prophylaxis. Methods and Results In this cluster …

Background Venous thromboembolism (VTE) is a leading cause of preventable mortality
among hospitalized patients, but appropriate risk assessment and thromboprophylaxis …

On May 4 and 5, 2022, a meeting of multidisciplinary stakeholders in the prevention and
treatment of venous thromboembolism (VTE) after trauma was convened by the Coalition for …

METHODS This is a secondary analysis of the 2018 to 2020 prospective, observational,
cohort Consortium of Leaders in the Study of Traumatic Thromboembolism (CLOTT) study of …

Objective: To examine the relationship between enoxaparin dose adequacy, quantified with
anti-Factor Xa (aFXa) levels, and 90-day symptomatic venous thromboembolism (VTE) and …